JP2017525770A5 - - Google Patents

Download PDF

Info

Publication number
JP2017525770A5
JP2017525770A5 JP2017530367A JP2017530367A JP2017525770A5 JP 2017525770 A5 JP2017525770 A5 JP 2017525770A5 JP 2017530367 A JP2017530367 A JP 2017530367A JP 2017530367 A JP2017530367 A JP 2017530367A JP 2017525770 A5 JP2017525770 A5 JP 2017525770A5
Authority
JP
Japan
Prior art keywords
group
substitution
aryl
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017530367A
Other languages
English (en)
Japanese (ja)
Other versions
JP6773655B2 (ja
JP2017525770A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/050490 external-priority patent/WO2016029263A1/en
Publication of JP2017525770A publication Critical patent/JP2017525770A/ja
Publication of JP2017525770A5 publication Critical patent/JP2017525770A5/ja
Application granted granted Critical
Publication of JP6773655B2 publication Critical patent/JP6773655B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017530367A 2014-08-25 2015-08-25 Mapk阻害剤 Active JP6773655B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014903342A AU2014903342A0 (en) 2014-08-25 Mapk inhibitors
AU2014903342 2014-08-25
PCT/AU2015/050490 WO2016029263A1 (en) 2014-08-25 2015-08-25 Mapk inhibitors

Publications (3)

Publication Number Publication Date
JP2017525770A JP2017525770A (ja) 2017-09-07
JP2017525770A5 true JP2017525770A5 (https=) 2018-09-27
JP6773655B2 JP6773655B2 (ja) 2020-10-21

Family

ID=55398500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017530367A Active JP6773655B2 (ja) 2014-08-25 2015-08-25 Mapk阻害剤

Country Status (6)

Country Link
US (2) US20170266173A1 (https=)
EP (1) EP3186245B1 (https=)
JP (1) JP6773655B2 (https=)
CN (1) CN107074831B (https=)
AU (1) AU2015309687B2 (https=)
WO (1) WO2016029263A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024265078A1 (en) 2023-05-04 2025-12-11 Revolution Medicines, Inc. Combination therapy for a ras related disease or disorder
IL326136A (en) 2023-08-07 2026-03-01 Revolution Medicines Inc RMC-6291 for use in the treatment of a disease or disorder associated with the RAS protein
US20250154171A1 (en) 2023-10-12 2025-05-15 Revolution Medicines, Inc. Ras inhibitors
WO2025171296A1 (en) 2024-02-09 2025-08-14 Revolution Medicines, Inc. Ras inhibitors
WO2025240847A1 (en) 2024-05-17 2025-11-20 Revolution Medicines, Inc. Ras inhibitors
US20250375445A1 (en) 2024-06-07 2025-12-11 Revolution Medicines, Inc. Methods of treating a ras protein-related disease or disorder
WO2025265060A1 (en) 2024-06-21 2025-12-26 Revolution Medicines, Inc. Therapeutic compositions and methods for managing treatment-related effects
WO2026006747A1 (en) 2024-06-28 2026-01-02 Revolution Medicines, Inc. Ras inhibitors
WO2026015825A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Use of ras inhibitor for treating pancreatic cancer
WO2026015796A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015801A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026015790A1 (en) 2024-07-12 2026-01-15 Revolution Medicines, Inc. Methods of treating a ras related disease or disorder
WO2026050446A1 (en) 2024-08-29 2026-03-05 Revolution Medicines, Inc. Ras inhibitors
WO2026072904A2 (en) 2024-09-26 2026-04-02 Revolution Medicines, Inc. Compositions and methods for treating lung cancer

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4174405A (en) * 1974-02-25 1979-11-13 Uniroyal, Inc. Thiophenes useful in control of acarids
US4381311A (en) 1980-12-29 1983-04-26 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl-α-(polyhalomethyl)-2-thiophenemethanols
JPS57134480A (en) * 1980-12-29 1982-08-19 Du Pont Antiinflammatory 4,5-diaryl-alpha- (polyhalomethyl)-2-thiophene methanols
US4749712A (en) * 1983-03-01 1988-06-07 E. I. Du Pont De Nemours And Company Antiinflammatory and/or analgesic 5-alkylthiophenes
GB9012936D0 (en) 1990-06-11 1990-08-01 Fujisawa Pharmaceutical Co Thiophene derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
US5571810A (en) * 1990-06-11 1996-11-05 Fujisawa Pharmaceutical Co., Ltd. Thiophene derivatives
US6428571B1 (en) 1996-01-22 2002-08-06 Scimed Life Systems, Inc. Self-sealing PTFE vascular graft and manufacturing methods
RU2222534C2 (ru) * 1997-04-24 2004-01-27 Орто-Макнейл Фармасьютикал, Инк. Замещенные имидазолы, способ их получения, фармацевтическая композиция на их основе, способы лечения цитокин-опосредованных заболеваний
ES2296910T3 (es) * 2001-01-22 2008-05-01 Sankyo Company, Limited Compuestos sustituidos con grupo amino biciclicos.
US6589997B2 (en) * 2001-06-29 2003-07-08 North Shore-Long Island Jewish Health System Small-molecule modulators of hepatocyte growth factor/scatter factor activities
US6544373B2 (en) 2001-07-26 2003-04-08 United Microelectronics Corp. Polishing pad for a chemical mechanical polishing process
US6835745B2 (en) * 2002-01-15 2004-12-28 Wyeth Phenyl substituted thiophenes as estrogenic agents
DE10217270A1 (de) 2002-04-18 2003-11-06 Wella Ag In 2-Stellung substituierte 3-Aminophenol-Derivate sowie diese Verbindungen enthaltende Färbemittel
US20040242673A1 (en) * 2003-05-16 2004-12-02 Ambit Biosciences Corporation Heterocyclic compounds and uses thereof
DE10343757A1 (de) * 2003-09-15 2005-04-21 Univ Dresden Tech Verfahren zur Schwermetall-freien Herstellung von N,N'-persubstituierten 5,5'-Diamino-2,2'bithiophenen und 2,2'-Diamino-5,5'-bithiazolen sowie deren Verwendung
JP2008001596A (ja) * 2004-09-03 2008-01-10 Astellas Pharma Inc ナトリウムチャネル阻害剤
US8835476B2 (en) * 2005-03-04 2014-09-16 Fan Wu Synthesis of novel antimicrobials
RU2008112691A (ru) * 2005-10-03 2009-10-10 Оно Фармасьютикал Ко., Лтд. (Jp) Азотсодержащее гетероциклическое соединение и его фармацевтическое применение
WO2007118149A2 (en) * 2006-04-07 2007-10-18 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical Lollege Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
JP5572968B2 (ja) * 2009-03-06 2014-08-20 大日本印刷株式会社 量子ドット発光材料、及び発光デバイス
CA2864085C (en) * 2012-02-08 2021-11-23 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
JP2017525770A5 (https=)
ES2630705T3 (es) Compuestos de piridilo sustituidos con triazolilo útiles como inhibidores de cinasas
Liu et al. New pqs quorum sensing system inhibitor as an antibacterial synergist against multidrug-resistant Pseudomonas aeruginosa
RU2681943C9 (ru) Соединения, полезные для лечения заболеваний, вызванных ретровирусами
JP2016512547A5 (https=)
CN114555588A (zh) 作为axl抑制剂的喹唑啉类化合物
JP2018522823A5 (https=)
RU2009128652A (ru) Замещенные циклоалкиламином производные изохинолина и изохинолинона
WO2010115836A4 (en) Substituted piperidines as ccr3 antagonists
JP2017505784A5 (https=)
JP2018507877A5 (https=)
JP2021515773A5 (https=)
JP2014037426A5 (https=)
JP6854386B2 (ja) リゾホスファチジン酸受容体1(lpar1)阻害剤化合物
WO2013066833A1 (en) Compounds and methods to inhibit histone deacetylase (hdac) enzymes
JP2017537948A (ja) Nadphオキシダーゼ阻害剤としてのアミドチアジアゾール誘導体
JP2013010792A5 (https=)
JP2015517981A5 (https=)
TN2014000033A1 (fr) Indazoles
JP2017524733A5 (https=)
JP2019537588A5 (https=)
HRP20180973T1 (hr) Supstituirani tiazolski ili oksazolski antagonisti p2x7 receptora
HRP20211282T1 (hr) Oksisteroli i postupci njihovog korištenja
JP2015508092A5 (https=)
RU2014135759A (ru) Конденсированные пирролдикарбоксамиды и их применение в качестве фармацевтических средств